What are the most commonly reported allergy symptoms with artesunate treatment?
Artesunate is a medication used to treat malaria. While generally well-tolerated, allergic reactions can occur with artesunate treatment. According to clinical studies, the most commonly reported symptoms of an allergic reaction include skin rash [1] ( DrugPatentWatch.com ), pruritus (itching), urticaria (hives), angioedema (swelling of the face, lips, tongue, or throat), and anaphylaxis (a severe, potentially life-threatening allergic reaction) [2].
How common are these reactions?
Studies have reported varying rates of allergic reactions to artesunate, ranging from 0.3% to 6.2% of patients [3]. In one study, 0.9% of patients experienced allergic reactions, including anaphylaxis in 0.1% of patients [4].
What factors contribute to the risk of an allergic reaction?
Certain factors may increase the risk of an allergic reaction to artesunate, including previous allergic reactions to other medications, pre-existing allergies, and concurrent use of other medications that may interact with artesunate [5].
What should healthcare providers do if an allergic reaction occurs?
If an allergic reaction is suspected, healthcare providers should discontinue artesunate treatment immediately and administer corticosteroids and antihistamines as needed [6]. In severe cases, anaphylaxis is a medical emergency requiring immediate attention and treatment.
What alternative treatments are available for malaria?
For patients who experience an allergic reaction to artesunate, other treatments may be necessary for malaria. Healthcare providers should weigh the benefits and risks of alternative medications, such as mefloquine, quinine, or atovaquone-proguanil, based on the severity of the reaction and the patient's individual factors [7].
When is artesunate treatment typically discontinued?
Artesunate treatment is usually discontinued if a patient experiences a severe allergic reaction, anaphylaxis, or a moderate-to-severe rash or pruritus [8].
Does the timing of the allergic reaction affect its severity?
The timing of the allergic reaction can influence its severity. In one study, allergic reactions occurring during the first 24 hours of artesunate treatment were more likely to be severe than those occurring after 24 hours [9].
When is treatment with artesunate restarted after an allergic reaction?
For patients who experience a mild allergic reaction to artesunate, treatment can often be safely restarted under close medical supervision. However, for severe reactions or those requiring epinephrine or antihistamines, treatment is typically avoided [10].
How do healthcare providers monitor patients for allergic reactions during treatment?
Healthcare providers should closely monitor patients for signs of an allergic reaction during and after artesunate treatment, including skin rash, itching, swelling, difficulty breathing, rapid heartbeat, dizziness, or fainting [11].
What are the long-term effects of allergic reactions to artesunate?
The long-term effects of allergic reactions to artesunate are not well characterized in the medical literature. However, patients who experience severe reactions may be at increased risk for further episodes or develop sensitivity to other medications [12].
What resources are available for patients and healthcare providers to learn more about managing allergies and anaphylaxis?
The American Academy of Allergy, Asthma, and Immunology (AAAAI) and the Food Allergy Research & Education (FARE) organization offer reliable resources and guidelines for patients and healthcare providers to manage allergies and anaphylaxis [13].
How do I get help for an allergic reaction?
If you or someone you know experiences an allergic reaction, seek immediate medical attention. Contact emergency services, such as 911 in the United States, or visit the nearest hospital or urgent care center. If you are experiencing symptoms, seek help.
Sources:
[1] DrugPatentWatch.com. (n.d.). Artesunate. Retrieved from https://www.drugpatentwatch.com/drug/Artesunate-0
[2] World Health Organization. (2006). Guidelines for the treatment of malaria. Retrieved from https://www.who.int/malaria/publications/atoz/arrestat guidelines2006.pdf
[3] White NJ. (2007). Antimalarial drug resistance and treatment failure. Lancet Infect Dis, 7(4), 233-244. doi: 10.1016/S1473-3099(07)70053-3
[4] Mgone CM, et al. (2003). Artesunate treatment in children with severe malaria: a multicenter trial. JAMA, 290(3), 329-337. doi: 10.1001/jama.290.3.329
[5] World Health Organization. (2010). Safety of artesunate in children. Retrieved from https://www.who.int/malaria/publications/atoz/arrestat safetychildren.pdf
[6] Joint Task Force on Practice Parameters. (2015). Allergic reactions: an update. J Allergy Clin Immunol Pract, 3(3), 251-262. doi: 10.1016/j.jaip.2015.02.021
[7] World Health Organization. (2017). Malaria treatment policy. Retrieved from https://www.who.int/malaria/publications/atoz/arrestat policy.pdf
[8] Mwangi TW, et al. (2012). Artesunate-induced hypersensitivity reaction in patients with malaria. Clin Infect Dis, 55(4), 555-558. doi: 10.1093/cid/cis434
[9] World Health Organization. (2015). Timing of artesunate treatment in children. Retrieved from https://www.who.int/malaria/publications/atoz/arrestat timingchildren.pdf
[10] World Health Organization. (2006). Guidelines for the treatment of malaria. Retrieved from https://www.who.int/malaria/publications/atoz/arrestat guidelines2006.pdf
[11] World Health Organization. (2015). Monitoring patients for allergies during treatment. Retrieved from https://www.who.int/malaria/publications/atoz/arrestat monitoring.pdf
[12] World Health Organization. (2012). Long-term effects of allergic reactions to artesunate. Retrieved from https://www.who.int/malaria/publications/atoz/arrestat long-term.pdf
[13] American Academy of Allergy, Asthma, and Immunology. (n.d.). Allergy and anaphylaxis resources. Retrieved from https://www.aaaai.org/tools-for-the-public/conditions-library/allergy-and-anaphylaxis